Personalizing Asthma Management for the Clinician.
Personalized medicine is a rapidly emerging area in health care, and asthma management lends itself particularly well to this new development. This practical resource by Dr. Stanley J. Szefler helps you navigate the many asthma medication options available to your patients, as well as providing insi...
Saved in:
| Online Access: |
Full Text (via ScienceDirect) |
|---|---|
| Main Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Elsevier Health Sciences,
2017.
|
| Subjects: |
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | b10246701 | ||
| 003 | CoU | ||
| 005 | 20181130031350.9 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 170929s2017 xx ob 001 0 eng d | ||
| 019 | |a 1005103452 |a 1024286511 | ||
| 020 | |a 032349708X |q (electronic bk.) | ||
| 020 | |a 9780323497084 |q (electronic bk.) | ||
| 020 | |z 0323485529 | ||
| 020 | |z 9780323485524 | ||
| 035 | |a (OCoLC)scd1004968703 | ||
| 035 | |a (OCoLC)1004968703 |z (OCoLC)1005103452 |z (OCoLC)1024286511 | ||
| 040 | |a IDEBK |b eng |e pn |c IDEBK |d EBLCP |d YDX |d N$T |d OPELS |d OCLCF |d CASUM |d OCLCQ |d U3W |d OCLCO |d OTZ |d UKMGB |d OCLCA | ||
| 049 | |a GWRE | ||
| 050 | 4 | |a RC591 | |
| 100 | 1 | |a Szefler, S. J. | |
| 245 | 1 | 0 | |a Personalizing Asthma Management for the Clinician. |
| 260 | |b Elsevier Health Sciences, |c 2017. | ||
| 300 | |a 1 online resource. | ||
| 336 | |a text |b txt |2 rdacontent. | ||
| 337 | |a computer |b c |2 rdamedia. | ||
| 338 | |a online resource |b cr |2 rdacarrier. | ||
| 505 | 0 | |a Front Cover; Personalizing Asthma Management for the Clinician; Personalizing Asthma Management for the Clinician; Copyright; List of Contributors; Preface; Foreword; Introduction; BACK TO THE BOOKS; RAPIDLY DEVELOPING SCIENCE; HEALTHCARE CHANGES; WHAT CAN YOU EXPECT TO LEARN?; Contents; 1 -- A Population Management Model of Asthma and Allergy: Case Finland; INTRODUCTION; FINNISH HEALTHCARE SYSTEM; INCREASE IN PREVALENCE AND NEED FOR TREATMENT; GETTING STARTED-ASTHMA PROGRAM STRATEGY; Paradigm Change; Early Detection, Timely Treatment; Burden Decreased; Costs Are Down. | |
| 505 | 8 | |a ASTHMA AND ALLERGY EPIDEMIC REMAINEDALLERGY PROGRAM STRATEGY; Contact-Person Network; Measuring Outcomes; ARE WE ON THE RIGHT TRACK?; LESSONS LEARNED; Some Tips; CONCLUSIONS; REFERENCES; 2 -- Population Health Management: A Systematic Approach to Asthma Care in a Pediatric Network of Care; INTRODUCTION; MANAGING A POPULATION OF CHILDREN WITH ASTHMA; Define the Priorities and Abilities of the Network of Care Leaders; Define the Geographic Region of Care; Identify Key Stakeholders and Assess the Needs; Identify the Target Population; Set Priorities; Build a Team and a Steering Committee. | |
| 505 | 8 | |a Collect Baseline Health DataTeam Education; IMPLEMENTATION EXAMPLE: CHILDREN'S HOSPITAL COLORADO; KEYS TO SUCCESS; Summary; REFERENCES; 3 -- Management of Severe Asthma in Adults: New Insights; INTRODUCTION; DEFINITION OF SEVERE ASTHMA; EPIDEMIOLOGY OF SEVERE ASTHMA; KEY FEATURES OF THE ASSESSMENT AND PATHOPHYSIOLOGY OF ASTHMA; TREATMENT; Anticholinergics; EOSINOPHILIC ASTHMA AND THE BIOLOGICS; Reslizumab; Benralizumab; Tralokinumab; Dupilumab; Bronchial thermoplasty; Macrolide antibiotics; SUMMARY AND FUTURE CONSIDERATIONS; REFERENCES. | |
| 505 | 8 | |a 4 -- Management and Prevention of Severe Asthma in ChildrenINTRODUCTION; DEFINITION OF SEVERE ASTHMA IN CHILDREN AND ADOLESCENTS; KEY FEATURES OF SEVERE ASTHMA IN CHILDREN; EARLY IDENTIFICATION OF SEVERE ASTHMA IN YOUNGER CHILDREN; ESTABLISHED MEDICATIONS FOR THE TREATMENT OF SEVERE ASTHMA IN CHILDREN; PHENOTYPE-DIRECTED TREATMENT STRATEGIES; Eosinophil-Predominant Type 2 Inflammatory Phenotype; Neutrophil-Predominant Inflammatory Phenotype; OTHER EMERGING TREATMENTS; FUTURE DIRECTIONS AND NEEDS; REFERENCES; 5 -- Exhaled Nitric Oxide as a Biomarker for Asthma Management; INTRODUCTION. | |
| 505 | 8 | |a HOW IS NITRIC OXIDE MEASURED AND HOW IS IT PRODUCED?FRACTION OF EXHALED NITRIC OXIDE IS A DIAGNOSTIC TEST FOR ASTHMA; FRACTION OF EXHALED NITRIC OXIDE AND WHEEZING PHENOTYPES; FRACTION OF EXHALED NITRIC OXIDE IS A DIAGNOSTIC TEST FOR ASTHMA; FRACTION OF EXHALED NITRIC OXIDE AND WHEEZING PHENOTYPES; FRACTION OF EXHALED NITRIC OXIDE IS A MEASURE OF ASTHMA SEVERITY AND CONTROL; FRACTION OF EXHALED NITRIC OXIDE IS A PREDICTOR OF ASTHMA RELAPSE DURING INHALED GLUCOCORTICOID REDUCTION; FRACTION OF EXHALED NITRIC OXIDE IS A PREDICTOR OF ASTHMA EXACERBATIONS. | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a Personalized medicine is a rapidly emerging area in health care, and asthma management lends itself particularly well to this new development. This practical resource by Dr. Stanley J. Szefler helps you navigate the many asthma medication options available to your patients, as well as providing insights into those which may be introduced within the next several years. | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Asthma |x Treatment. | |
| 650 | 7 | |a Asthma |x Treatment. |2 fast |0 (OCoLC)fst00819329. | |
| 776 | 0 | 8 | |i Print version: |z 0323485529 |z 9780323485524 |w (OCoLC)969546421. |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=https://www.sciencedirect.com/science/book/9780323485524 |z Full Text (via ScienceDirect) |
| 907 | |a .b102467018 |b 05-31-23 |c 12-18-18 | ||
| 998 | |a web |b - - |c f |d b |e - |f eng |g xx |h 0 |i 1 | ||
| 915 | |a M | ||
| 956 | |a ScienceDirect ebooks | ||
| 956 | |b ScienceDirect All Books | ||
| 999 | f | f | |i 2157cde6-a8e7-5f41-a0c2-5d44ea365155 |s f748e63b-6377-5d92-b814-e7e28f5dc58f |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e RC591 |h Library of Congress classification |i web |n 1 |